Back to Search
RICHARD SHAMES, MD
MD
Pediatric Allergy/Immunology Physician
NPI: 1538294855Individual
Specialties, Licenses & Credentials
Pediatric Allergy/Immunology PhysicianPrimary
Pediatrics — Pediatric Allergy/Immunology
Code: 2080P0201X
G65774(CA)
Research & Publications (7)
Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.
PMID 16971643·J Clin Microbiol·2006
7-preclinical
Effectiveness of a multicomponent self-management program in at-risk, school-aged children with asthma.
PMID 15237762·Ann Allergy Asthma Immunol·2004
3-trial
Gender differences in the development and function of the immune system.
PMID 11943576·J Adolesc Health·2002
6-review
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.
PMID 18787222·Am J Respir Crit Care Med·2008
2-rct
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.
PMID 16603634·Gut·2006
4-observational
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
PMID 14599854·J Autoimmun·2003
3-trial
Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma.
PMID 12359798·Pediatrics·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 725 WELCH RD
PALO ALTO, CA 94304 - Phone
- (650) 723-4000
Quick Facts
- NPI
- 1538294855
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile